Tag: Johnson & Johnson

Nanobiotix achieves milestone in cancer treatment with NBTXR3, secures $20m from Janssen

businessnewstoday- January 30, 2024

NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX), a leader in the field of biotechnology, announced a significant achievement in its ongoing pivotal Phase 3 study, NANORAY-312. ... Read More

Bausch + Lomb acquires Johnson & Johnson Vision’s Blink product line

businessnewstoday- July 9, 2023

Bausch + Lomb, an esteemed global eye health company, has broadened its portfolio by purchasing Johnson & Johnson Vision's Blink product line for $106.5 million. ... Read More

Marksans Pharma gets FDA final approval for Famotidine Tablets

businessnewstoday- March 12, 2023

Marksans Pharma said that it has been granted final approval for the over-the-counter (OTC) use of Famotidine Tablets USP, 10 mg and 20 mg from ... Read More

Johnson & Johnson completes $17bn acquisition of Abiomed

Raghuram Kadari- December 28, 2022

Johnson & Johnson (J&J) has closed the previously announced acquisition of Abiomed, a medical device technology company, for an enterprise value of around $16.6bn, in ... Read More

Johnson & Johnson to purchase heart pump maker Abiomed for $16.6bn

Raghuram Kadari- November 2, 2022

Johnson & Johnson (J&J) has agreed to acquire Abiomed, a NASDAQ-listed cardiovascular medical technology provider, in an all-cash deal valued at approximately $16.6 billion. The ... Read More

FDA approves Janssen’s TECVAYLI for multiple myeloma treatment

businessnewstoday- October 27, 2022

The Janssen Pharmaceutical Companies, a subsidiary of Johnson & Johnson, announced the US Food and Drug Administration's approval of its first bispecific T-cell engager antibody, ... Read More

Granules India gets FDA approval for Loperamide Hydrochloride and Simethicone Tablets

pallavi123- August 30, 2022

Granules India has secured approval for its abbreviated new drug application (ANDA) for Loperamide Hydrochloride and Simethicone Tablets, 2 mg/125 mg (OTC) from the US ... Read More

Healthcare giant Johnson & Johnson to spin off consumer health business

businessnewstoday- November 15, 2021

Johnson & Johnson (JNJ) has announced plans to carve out its consumer health business into a new publicly traded company to focus on its biopharma ... Read More

Janssen Covid‑19 vaccine gets conditional marketing authorization in EU

pallavi123- March 27, 2021

The European Commission has granted a conditional marketing authorization (CMA) for the single dose Janssen Covid‑19 vaccine developed by the Janssen Pharmaceutical Companies of Johnson ... Read More

J&J Ad26.COV2.S COVID-19 vaccine gets FDA emergency use authorization

pallavi123- February 28, 2021

Johnson & Johnson (J&J) said that the US Food and Drug Administration (FDA) has given emergency use authorization (EUA) for Ad26.COV2.S, a single-dose COVID-19 vaccine ... Read More